Check out our most popular compounded medications! Get Started
The Sodium Valproate 500 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug administration. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing tablets or capsules, such as children and the elderly. Sodium Valproate is commonly used in the treatment of epilepsy for the control of seizures, as well as in the management of bipolar disorder, providing mood stabilization. The liquid form ensures accurate dosing and ease of use for those requiring tailored pharmacological therapy for these disease states.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Sodium Valproate 500 mg/5 mL Oral Liquid is a carefully compounded medication designed for oral use, particularly beneficial for patients who experience difficulty swallowing tablets or capsules, such as children and the elderly. This liquid formulation ensures precise dosing and ease of administration, which is critical for maintaining therapeutic drug levels and optimizing patient compliance. Sodium Valproate is a well-established medication, primarily used in the management of seizure disorders, including epilepsy. It functions as an anticonvulsant by increasing the availability of gamma-aminobutyric acid (GABA) in the brain, which helps to stabilize neuronal activity and prevent seizure episodes.
In addition to its anticonvulsant properties, Sodium Valproate is also utilized in the treatment of bipolar disorder, where it acts as a mood stabilizer, and in the prevention of migraine headaches. Its efficacy in these conditions is attributed to its ability to modulate neurotransmitter signaling, thereby exerting a calming effect on the nervous system. The liquid form of Sodium Valproate is particularly advantageous for individualized dosing regimens, as it allows for adjustments to be made easily and accurately, catering to the specific needs of each patient.
It is important for both patients and prescribers to be aware of the potential side effects associated with Sodium Valproate, which may include gastrointestinal disturbances, changes in liver function, and possible effects on blood cell counts. Regular monitoring of blood levels and liver function tests are recommended to ensure safe and appropriate use of the medication. As with any medication, adherence to prescribed dosages and schedules is crucial, and any concerns or adverse effects should be promptly discussed with a healthcare professional.
At Bayview Pharmacy, we are committed to providing high-quality, patient-specific formulations. Our team of expert compounding pharmacists is available to answer any questions and provide guidance on the use of Sodium Valproate 500 mg/5 mL Oral Liquid. We work closely with prescribers to ensure that each formulation meets the unique needs of the patient, ensuring therapeutic efficacy and safety. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us.
Sodium valproate is an anticonvulsant medication used to treat various forms of epilepsy, bipolar disorder, and to prevent migraine headaches. When considering the use of sodium valproate 500 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
One significant interaction is with other medications that affect the central nervous system (CNS), such as other antiepileptics, benzodiazepines, antipsychotics, antidepressants, and sedatives. The concurrent use of these medications with sodium valproate can lead to increased CNS depression, resulting in excessive drowsiness, dizziness, or respiratory depression. Caution is advised when combining these drugs, and dosage adjustments may be necessary.
Sodium valproate can also affect the metabolism of other drugs by inhibiting liver enzymes, particularly those in the cytochrome P450 system. This can lead to increased levels of drugs like warfarin, leading to a higher risk of bleeding. Patients taking warfarin should have their blood clotting time or INR monitored closely when starting or changing doses of sodium valproate.
Additionally, sodium valproate can displace other drugs from plasma protein binding sites, which can increase the free concentration of drugs like phenytoin, carbamazepine, and lamotrigine. This displacement can lead to toxicity of these drugs, so monitoring of drug levels and clinical signs of toxicity is recommended when these drugs are used concurrently with sodium valproate.
Valproate can also increase the levels of certain drugs by inhibiting their glucuronidation, such as lamotrigine, leading to a potential increase in adverse effects like skin rashes. Dose adjustments of lamotrigine may be necessary when used in combination with sodium valproate.
Conversely, drugs that induce liver enzymes, such as rifampin, carbamazepine, and phenytoin, can decrease the levels of valproate, potentially reducing its efficacy. Patients may require dose adjustments of sodium valproate when starting or stopping these medications.
Valproate has been associated with an increased risk of hyperammonemia, and this risk may be further increased when taken with other medications that can also cause hyperammonemia, such as topiramate. Clinical monitoring for signs and symptoms of hyperammonemia is advised when these drugs are used together.
Lastly, valproate can interfere with the metabolism of certain antiretroviral drugs used in the treatment of HIV. This can either increase the risk of adverse effects or reduce the efficacy of the antiretroviral drugs. Close monitoring and possible dose adjustments are necessary when these drugs are co-administered.
It is crucial for patients and prescribers to be aware of these potential interactions and to monitor for any signs of adverse effects or changes in drug efficacy. Always inform your healthcare provider of all medications, supplements, and herbal products you are taking before starting treatment with sodium valproate. If you have any questions or concerns about drug interactions with sodium valproate 500 mg/5 mL oral liquid, please reach out to us at Bayview Pharmacy for further assistance.
Sodium Valproate 500 mg/5 mL Oral Liquid is a specially designed medication that is administered orally. This formulation is particularly beneficial for patients who have difficulty swallowing pills or capsules, such as children and the elderly. The liquid form allows for precise dosing, which is crucial for maintaining therapeutic levels of the medication in the bloodstream. Sodium valproate, the active ingredient, is a well-established drug used in the treatment of various seizure disorders, including epilepsy. It is also used in the management of bipolar disorder and to prevent migraine headaches.
The mechanism by which sodium valproate exerts its effects is multifaceted. It is thought to increase the concentration of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter that inhibits nerve transmission in the brain, calming nervous activity. By enhancing the action of GABA, sodium valproate can help to stabilize electrical activity in the brain and prevent seizures. Additionally, sodium valproate inhibits the breakdown of GABA and may also block voltage-gated sodium channels, which contributes to its anticonvulsant properties.
In the treatment of bipolar disorder, sodium valproate helps to stabilize mood by modulating neurotransmitter signaling, although the exact mechanism in this context is not fully understood. For migraine prevention, sodium valproate is believed to affect the underlying brain mechanisms that trigger migraines, although its precise action in this indication is also not completely clear.
Regular monitoring of liver function and blood counts is recommended due to potential side effects. The dose of sodium valproate must be individualized based on the patient's specific condition, age, and response to the medication. This oral liquid formulation allows for flexible dosing, which can be adjusted to meet the patient's needs.
For any questions regarding the use of Sodium Valproate 500 mg/5 mL Oral Liquid, or to discuss the suitability of this medication for a particular patient, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of this medication.
Sodium Valproate oral liquid is used to treat various forms of epilepsy. It works by stabilizing electrical activity in the brain, helping to prevent or control seizures. It may also be prescribed for the treatment of bipolar disorder if a doctor deems it appropriate.
This medication should be taken according to your doctor’s instructions. The liquid formulation is usually administered using a dosing syringe or spoon to ensure the accurate measurement of the dose. It can be taken with or without food. Be sure to shake the bottle well before each use.
No, the oral liquid form of Sodium Valproate is designed to be swallowed. Do not crush, chew, or alter the consistency of the liquid as this may affect the release and absorption of the medication.
If you miss a dose of Sodium Valproate Oral Liquid, take it as soon as you remember, unless it is close to the time of your next dose. In that case, skip the missed dose and resume your usual dosing schedule. Do not take a double dose to make up for a missed one.
It's generally recommended to take the medication on its own to ensure you get the correct dose. However, if you have difficulties, you may consult with your doctor or pharmacist regarding the safe mixing of the medication with certain foods or drinks.
Common side effects may include drowsiness, dizziness, nausea, vomiting, and tremors. If these persist or worsen, or if you experience significant changes in mood or behavior, please contact your healthcare provider immediately.
Sodium Valproate has known risks during pregnancy and should only be used if clearly necessary, as it can harm an unborn baby. Always consult with your doctor before taking this medication if you are pregnant, planning a pregnancy, or breastfeeding.
Yes, the liquid form of Sodium Valproate is often prescribed for children who cannot swallow tablets, as it allows for accurate dosing. The dosage should be carefully determined by a pediatrician based on the child's weight and medical condition.
Store the medication at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use. Be sure to keep this medication out of the reach of children and pets.
No, you should not stop taking Sodium Valproate Oral Liquid without consulting your doctor, even if you feel better. Abruptly stopping the medication can lead to a recurrence of symptoms or cause withdrawal effects. If a decision is made to discontinue use, your doctor will guide you on how to taper off safely.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
